Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

895
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
895
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

770
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
770
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

900
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
900
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of increased coronary physiology and intracoronary imaging use with downstream healthcare costs.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Efficacy and safety of atrial fibrillation ablation in patients with Marfan syndrome: A multicenter analysis.

Heart rhythm O2·2026
Same author

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same author

The Role of Multimodality Imaging in Guiding Ventricular Tachycardia Ablation: An Updated Review.

Reviews in cardiovascular medicine·2026
Same author

Cardiac surgical outcomes and predictors of redo sternotomy in patients with Marfan syndrome: a retrospective multicentre cohort study.

Open heart·2026
Same author

GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated Lp(a) levels: A Multicenter retrospective study.

International journal of cardiology·2026

相关实验视频

Updated: Jun 3, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.3K

在心房管理的进步:一般内科医生的指南.

Hoang Nhat Pham1, Ramzi Ibrahim2, Hong Hieu Truong3

  • 1Department of Medicine, University of Arizona, Tucson, AZ 85719, USA.

Journal of clinical medicine
|January 8, 2025
PubMed
概括

新的心房指南强调早期检测和以患者为中心的护理. 一般内科医生可以通过采用这些更新的策略来管理这种常见的心律失常,从而改善患者的治疗结果.

关键词:
心房动是心房动的一种.这些指导方针是指导方针.改变生活方式 改变生活方式管理的管理管理的管理.风险因素的修改 风险因素的修改

更多相关视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K

相关实验视频

Last Updated: Jun 3, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.3K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K

科学领域:

  • 心脏病学 心脏病学
  • 内部医学 内部医学
  • 公共卫生 公共卫生

背景情况:

  • 心房动 (AF) 是美国最常见的持续心律失常,影响数百万,预计到2030年将翻一番.
  • AF显著增加中风和其他心血管事件的风险,导致显著的发病率和死亡率.
  • 当前的管理模式正在不断发展,以应对AF日益增长的负担.

研究的目的:

  • 审查2023年ACC/AHA/ACCP/HRS指南,用于心房的诊断和管理.
  • 为一般内科医生提供有关更新的,以患者为中心的AF护理方法的见解.
  • 要突出从基于持续时间的分类转向以风险因素为中心的综合战略的转变.

主要方法:

  • 对2023年ACC/AHA/ACCP/HRS指南的分析.
  • 检查了新的AF分类系统,强调早期检测和干预.
  • 对多学科护理模式和初级保健提供者角色的建议的审查.

主要成果:

  • 这些指南引入了转向以患者为中心的方法的范式转变,超越了基于持续时间的AF分类.
  • 一个新的分类系统优先考虑早期检测,风险因素评估和量身定制的生活方式修改.
  • 重点放在多学科护理模式上,赋予初级保健提供者主动AF管理的权力.

结论:

  • 更新的指南提供了一个全面的框架,有效地管理心房动.
  • 一般内科医生在实施风险因素管理和生活方式干预措施以预防和照顾AF方面是至关重要的.
  • 采用这些指导方针可以提高患者的治疗结果,并应对AF管理的不断变化的局面.